ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.35
0.54%
US Tech 100
18,427.40
1.39%
S&P 500
5,327.22
0.68%
US Dollar vs CAD
1.37069
0.22%
Bitcoin
71,670.66
1.49%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Inhibrx Biosciences Inc (INBX)

  7. Inhibrx Biosciences Inc (INBX) News

INBX Inhibrx Biosciences Inc

17.79
0.58 (3.37%)
Last Updated: 11:00:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inhibrx Biosciences Inc INBX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.58 3.37% 17.79 11:00:01
Open Price Low Price High Price Close Price Previous Close
18.33 17.555 18.95 17.21
more quote information »

Recent News

Date Time Source Heading
5/31/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202417:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/30/202415:34EDGAR2Form S-8 POS - Securities to be offered to employees in..
5/30/202415:32EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
5/30/202415:13EDGAR2Form 8-K - Current report
5/28/202415:55EDGAR2Form 144 - Report of proposed sale of securities
5/24/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/24/202415:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
5/24/202415:08EDGAR2Form 8-K - Current report
5/24/202415:00PRNUSInhibrx Inc. Stockholders Approve Sale of INBRX-101 to..
5/22/202408:54EDGAR2Form 144 - Report of proposed sale of securities
5/20/202420:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/17/202416:29EDGAR2Form 8-K - Current report
5/17/202415:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
5/10/202417:36PRNUSInhibrx, Inc. Announces Updated When-Issued Trading Date for..
5/09/202415:08EDGAR2Form 8-K - Current report
5/08/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202415:42EDGAR2Form 8-K - Current report
5/08/202415:37PRNUSInhibrx, Inc. Announces Record Date and Expected..
5/06/202416:16EDGAR2Form 144 - Report of proposed sale of securities
3/11/202415:26EDGAR2Form 144 - Report of proposed sale of securities
3/08/202415:08EDGAR2Form 144 - Report of proposed sale of securities
3/08/202414:28EDGAR2Form 144 - Report of proposed sale of securities
3/06/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202413:58EDGAR2Form 144 - Report of proposed sale of securities
3/04/202417:26EDGAR2Form 144 - Report of proposed sale of securities
2/29/202416:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2/28/202408:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
2/28/202408:12EDGAR2Form 8-K - Current report
2/28/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/14/202415:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/26/202411:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
1/23/202416:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202405:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202405:35EDGAR2Form 8-K - Current report
1/23/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
1/23/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
11/09/202315:03EDGAR2Form 8-K - Current report
11/09/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
11/02/202308:16EDGAR2Form 8-K - Current report
11/02/202308:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
10/18/202315:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
9/19/202315:03EDGAR2Form 8-K - Current report
9/19/202315:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
8/29/202308:03EDGAR2Form 8-K - Current report
8/29/202308:00PRNUSInhibrx Announces $200 Million Private Placement Financing
8/07/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
INBX
Inhibrx Biosciences
HITB
PMAETH
PumaPay
COIN
MONKUSD
MonkCoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved